We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ahead of Kenvue (KVUE) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Analysts on Wall Street project that Kenvue (KVUE - Free Report) will announce quarterly earnings of $0.22 per share in its forthcoming report, representing a decline of 21.4% year over year. Revenues are projected to reach $3.68 billion, declining 5.5% from the same quarter last year.
Over the last 30 days, there has been a downward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
In light of this perspective, let's dive into the average estimates of certain Kenvue metrics that are commonly tracked and forecasted by Wall Street analysts.
The average prediction of analysts places 'Net Sales- Self Care' at $1.61 billion. The estimate points to a change of -5.1% from the year-ago quarter.
Based on the collective assessment of analysts, 'Net Sales- Essential Health' should arrive at $1.07 billion. The estimate indicates a year-over-year change of -6.2%.
Analysts predict that the 'Net Sales- Skin Health and Beauty' will reach $980.93 million. The estimate indicates a change of -6.9% from the prior-year quarter.
The consensus among analysts is that 'Adjusted Operating Income- Self Care' will reach $557.79 million. The estimate is in contrast to the year-ago figure of $606 million.
Analysts forecast 'Adjusted Operating Income- Essential Health' to reach $89.22 million. Compared to the current estimate, the company reported $256 million in the same quarter of the previous year.
Analysts expect 'Adjusted Operating Income- Skin Health and Beauty' to come in at $121.28 million. Compared to the present estimate, the company reported $149 million in the same quarter last year.
Shares of Kenvue have demonstrated returns of +7.4% over the past month compared to the Zacks S&P 500 composite's +0.4% change. With a Zacks Rank #3 (Hold), KVUE is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Ahead of Kenvue (KVUE) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Analysts on Wall Street project that Kenvue (KVUE - Free Report) will announce quarterly earnings of $0.22 per share in its forthcoming report, representing a decline of 21.4% year over year. Revenues are projected to reach $3.68 billion, declining 5.5% from the same quarter last year.
Over the last 30 days, there has been a downward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
In light of this perspective, let's dive into the average estimates of certain Kenvue metrics that are commonly tracked and forecasted by Wall Street analysts.
The average prediction of analysts places 'Net Sales- Self Care' at $1.61 billion. The estimate points to a change of -5.1% from the year-ago quarter.
Based on the collective assessment of analysts, 'Net Sales- Essential Health' should arrive at $1.07 billion. The estimate indicates a year-over-year change of -6.2%.
Analysts predict that the 'Net Sales- Skin Health and Beauty' will reach $980.93 million. The estimate indicates a change of -6.9% from the prior-year quarter.
The consensus among analysts is that 'Adjusted Operating Income- Self Care' will reach $557.79 million. The estimate is in contrast to the year-ago figure of $606 million.
Analysts forecast 'Adjusted Operating Income- Essential Health' to reach $89.22 million. Compared to the current estimate, the company reported $256 million in the same quarter of the previous year.
Analysts expect 'Adjusted Operating Income- Skin Health and Beauty' to come in at $121.28 million. Compared to the present estimate, the company reported $149 million in the same quarter last year.
View all Key Company Metrics for Kenvue here>>>
Shares of Kenvue have demonstrated returns of +7.4% over the past month compared to the Zacks S&P 500 composite's +0.4% change. With a Zacks Rank #3 (Hold), KVUE is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>